Showing results (131-140 of 187) with videos related to

Sort By:
Pageof 19
Plant Physiology|November 15, 2017
The RIN-MC Fusion of MADS-Box Transcription Factors Has Transcriptional Activity and Modulates Expression of Many Ripening GenesShan Li, Huijinlan Xu, Zheng Ju, et al.
Frontiers in Oncology|December 18, 2018
Piver Type II vs. Type III Hysterectomy in the Treatment of Early-Stage Cervical Cancer: Midterm Follow-up Results of a Randomized Controlled TrialHengzi Sun, Dongyan Cao, Keng Shen, et al.
Plant Physiology|February 24, 2017
A Viral Satellite DNA Vector (TYLCCNV) for Functional Analysis of miRNAs and siRNAs in PlantsZheng Ju, Dongyan Cao, Chao Gao, et al.
Oncotarget|February 11, 2016
The prognostic value of pretreatment CA-125 levels and CA-125 normalization in ovarian clear cell carcinoma: a two-academic-institute studyHuimin Bai, Guisha Sha, Meizhu Xiao, et al.
World Journal of Surgical Oncology|August 16, 2017
Oncofertility in patients with stage I epithelial ovarian cancer: fertility-sparing surgery in young women of reproductive ageXuan Jiang, Jiaxin Yang, Mei Yu, et al.
Nature Communications|June 12, 2021
Analysis of the genomic landscape of yolk sac tumors reveals mechanisms of evolution and chemoresistanceXuan Zong, Ying Zhang, Xinxin Peng, et al.
Frontiers in Oncology|September 27, 2021
Management of Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Patients After Primary Fertility-Sparing TherapyJunyu Chen, Dongyan Cao, Jiaxin Yang, et al.
Gynecologic Oncology|August 2, 2012
A clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumorsTing Gui, Dongyan Cao, Keng Shen, et al.
Gynecologic Oncology|May 15, 2026
Longitudinal trajectories of anxiety and depression in patients with endometrial cancer or atypical endometrial hyperplasia undergoing fertility-sparing treatmentYing Cao, Qian Liu, Huimei Zhou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 22, 2026
Gonadotropin-releasing hormone agonist plus aromatase inhibitor versus oral progestins for fertility-sparing treatment in early endometrial carcinoma and atypical hyperplasia: interim analysis of a prospective controlled trialQian Liu, Huimei Zhou, Mei Yu, et al.
Pageof 19